Wagner-Drouet, E., Teschner, D., Wolschke, C., Janson, D., Schafer-Eckart, K., Gartner, J., . . . Wolff, D. (2019). Standardized monitoring of cytomegalovirusspecific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation. Haematologica.
Citação norma ChicagoWagner-Drouet, Eva, et al. "Standardized Monitoring of Cytomegalovirusspecific Immunity Can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation After Hematopoietic Stem Cell Transplantation." Haematologica 2019.
Deismireacht MLAWagner-Drouet, Eva, et al. "Standardized Monitoring of Cytomegalovirusspecific Immunity Can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation After Hematopoietic Stem Cell Transplantation." Haematologica 2019.